← Back to Clinical Trials
Recruiting NCT07422714

NCT07422714 Application of a Wearable Device-Based Intelligent Rehabilitation System in the Rehabilitation of Patients With Frozen Shoulder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07422714
Status Recruiting
Phase
Sponsor Peking University Third Hospital
Condition Range of Motion, Articular
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2026-01-21
Primary Completion 2026-03-31

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Artificial and intelligent combination of shoulder joint function exerciseTraditional rehabilitation trainingIntelligent rehabilitation training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2026-01-21 with a primary completion date of 2026-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A Comparative Study of Traditional Rehabilitation and Remote Intelligent Rehabilitation: Exploring the Application Effectiveness of Intelligent Rehabilitation in Frozen Shoulder Rehabilitation

Eligibility Criteria

Inclusion Criteria:① Subjects are aged between 40 and 60 years (inclusive), regardless of gender; * Diagnosed with the adhesive phase of frozen shoulder by the Department of Sports Medicine, with patients potentially coming from different physicians; * Have not participated in any other clinical trials within the past 3 months; ④ Patients voluntarily agree to participate in the clinical trial, sign the informed consent form, and are able to cooperate with clinical follow-up. Exclusion Criteria:① Patients with combined cardiovascular or cerebrovascular diseases, severe liver or kidney dysfunction, coagulation disorders, severe electrocardiogram abnormalities, etc.; * Patients with local lesions in the affected shoulder or arm, such as skin damage, infection, tuberculosis, tumors, or skin diseases; * Patients with poor physical condition who are unable to tolerate the intensity of rehabilitation training; ④ Patients with cognitive impairments who cannot undergo normal rehabilitation training, or other conditions deemed by the physician as unsuitable for trial participation; ⑤ Pregnant or breastfeeding women; ⑥ Patients with other shoulder conditions, such as rotator cuff tears or shoulder dislocation.

Contact & Investigator

Central Contact

Zhenlong Liu

✉ zhenlong_liu@bjmu.edu.cn

📞 13261993917

Frequently Asked Questions

Who can join the NCT07422714 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Range of Motion, Articular. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07422714 currently recruiting?

Yes, NCT07422714 is actively recruiting participants. Contact the research team at zhenlong_liu@bjmu.edu.cn for enrollment information.

Where is the NCT07422714 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT07422714 clinical trial?

NCT07422714 is sponsored by Peking University Third Hospital. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology